You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Pancreatic adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Pancreatic Adenocarcinoma Trial in Stanford (ExAblate 2100)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • ExAblate 2100
  • Stanford, California
    Stanford Cancer Center
Oct 25, 2022

Locally Advanced Pancreatic Adenocarcinoma Trial in Houston (SD-101, pebrolizumab)

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Nov 18, 2022

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Pancreatic Cancer Trial (Rintatolimod)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Aug 8, 2022

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Cholesterol metabolism disruption
  • Quebec city, Quebec, Canada
    CHU de Québec-Université Laval
Oct 17, 2022

Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fairway, Kansas
    Kansas University Cancer center
Nov 2, 2022

Locally Advanced Pancreatic Cancer Trial (FOLFIRINOX chemo, OncoSil™)

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • FOLFIRINOX chemotherapy
  • OncoSil™
  • (no location specified)
Jul 18, 2022

Survival, Quality of Life and Resectability in Locally Advanced

Recruiting
  • Pancreas Cancer
  • +8 more
    • Umeå, Sweden
      Surgical Clinic at Umeå University Hospital
    Nov 23, 2022

    Pancreatic Adenocarcinoma Trial in Los Angeles (Pancrelipase)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jul 15, 2022

    Carcinoma, Pancreatic Ductal, Prognosis Trial in Clichy, Lille, Saint-Cloud (Clinical value of 5 transcriptomic signatures to

    Not yet recruiting
    • Carcinoma, Pancreatic Ductal
    • Prognosis
    • Clinical value of 5 transcriptomic signatures to personalize the therapeutic decision for L1 in PDAC
    • Biomarkers of tumor signatures (translational studies)
    • Clichy, France
    • +2 more
    Jul 25, 2022

    Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago

    Terminated
    Has Results
    • Pancreatic Adenocarcinoma
    • +2 more
    • Pembrolizumab
    • Wild-type Reovirus
    • Chicago, Illinois
      Northwestern University
    Sep 6, 2022

    Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Unresectable

    Not yet recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Biospecimen Collection
    • +8 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 9, 2023

    Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable Trial in Seoul (SBRT+mFOLFIRINOX, mFOLFIRINOX)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Pancreatic Cancer Non-resectable
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 24, 2022

    Advanced Pancreatic Cancer Trial in Shanghai (APG-1387 for Injection, Gemcitabine, Nab paclitaxel)

    Recruiting
    • Advanced Pancreatic Cancer
    • APG-1387 for Injection
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jan 26, 2022

    Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +2 more
    • Enfortumab vedotin
    • Kansas City, Kansas
      University of Kansas Cancer Center
    Jun 23, 2023

    Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Beverly Hills, Los Angeles

    Recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Beverly Hills, California
    • +1 more
    Jun 16, 2022

    Pancreatic Cancer Trial (Adavosertib, Gemcitabine)

    Withdrawn
    • Pancreatic Cancer
    • (no location specified)
    Jun 10, 2022

    Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

    Recruiting
    • Advanced Fallopian Tube Carcinoma
    • +21 more
    • Biopsy
    • +2 more
    • Bethesda, Maryland
    • +2 more
    Jan 25, 2023

    Pancreatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma Trial in United States (Gemcitabine, Nab-paclitaxel, PEGPH20)

    Active, not recruiting
    • Pancreatic Cancer
    • Advanced Pancreatic Ductal Adenocarcinoma
    • Hartford, Connecticut
    • +9 more
    Jul 15, 2022

    Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

    Not yet recruiting
    • Locally Advanced Unresectable Pancreatic Adenocarcinoma
    • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
    • (no location specified)
    Jun 25, 2023

    Pancreatic Ductal Adenocarcinoma Trial in United States (NALIRIFOX, AD-XRT and Capecitabine)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Basking Ridge, New Jersey
    • +6 more
    May 15, 2023

    Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • mFOLFIRINOX plus radiotherapy
    • (no location specified)
    Nov 21, 2023

    Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)

    Not yet recruiting
    • Pancreatic Cancer
    • +2 more
    • DaRT seeds insertion
    • (no location specified)
    Sep 5, 2023

    Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Charlottesville (EGFR BATs after

    Recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • Metastatic Pancreatic Adenocarcinoma
    • EGFR BATs after standard of care chemo
    • Charlottesville, Virginia
      University of Virginia
    Mar 30, 2022